Skip to main content

Displaying 881 - 900 of 1530

Novartis AG, In the Matter of (Alcon, Inc)

To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the FTC alleges that the acquisition would have created a monopoly in injectable miotics. The settlement requires Novartis to sell its drug Miochol-E to Bausch & Lomb, Inc.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
101 0068
Docket Number
C-4296

Carilion Clinic, a corporation, In the Matter of

The Commission issued an administrative complaint challenging Carilion Clinic’s 2008 acquisition of two competing outpatient clinics in the Roanoke, Virginia, area. The complaint alleges that Carilion’s acquisition of these outpatient centers eliminated competition for patients in the Roanoke area.  On October 7, 2009 Carillion agreed to sell two independent outpatient medical clinics it acquired last year to settle the charges.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0810259
Docket Number
9338

Arkansas Carpenters Health and Welfare Fund, et. al v. Bayer AG, et. al (In re Ciprofloxacin Hydrochloride Antitrust Litigation)

Date
Citation Number
05-2851 & 05-2852
Federal Court
U.S. Circuit Court of Appeals for the Second Circuit
An amicus brief in support of plaintiffs-appellants’ petition for rehearing en banc. The case concerns a court of appeals panel decision upholding the dismissal of an antitrust challenge to a Hatch...